Press Release Medical Technology/Healthcare 1 min read

Field Medical Closes Oversubscribed $35 Million Series B to Advance Development of FieldForce™ Pulsed Field Ablation Platform

Field Medical, a clinical-stage company developing pulsed field ablation technology for cardiac arrhythmias, closed a $35 million Series B financing round co-led by BioStar Capital and Cue Growth, with participation from existing strategic investors. The funds will support the initiation of the pivotal VERITAS trial and further development of the FieldForce Ablation System.

Field Medical Inc.
Press ReleaseJuly 2, 2025
Field Medical

Field Medical, a clinical-stage company developing pulsed field ablation technology for cardiac arrhythmias, closed a $35 million Series B financing round co-led by BioStar Capital and Cue Growth, with participation from existing strategic investors. The funds will support the initiation of the pivotal VERITAS trial and further development of the FieldForce Ablation System.

Related articles

Press ReleaseSeptember 16, 2026
ASSA ABLOY

ASSA ABLOY acquires PACLOCK in the US

September 16, 2026
Press ReleaseSeptember 16, 2026
MySize

MySize Announces $2.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

September 16, 2026
Press ReleaseSeptember 16, 2026
Xpansiv

Xpansiv to Acquire Formbay, Australia's AI-Enabled Renewable Energy Certificate and Compliance Technology Platform

September 16, 2026
← Back to all articles

Generated by Olivia 6